IYIman K. Yazdi

Iman K. Yazdi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Iman K. Yazdi has a total of 120 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Engineering Stem Cell Fate Controlling Biomaterials to Develop Muscle Connective Tissue Layered Myofibers

    by Seokgyu Han, Myung Chul Lee, Alejandra Rodríguez‐Delarosa, Jiseong Kim, Margot Barroso‐Zuppa, Montserrat Pineda‐Rosales, Seong Soo Kim, Takaaki Hatanaka, Iman K. Yazdi, Nicole Bassous, et al.

    Skeletal muscle connective tissue (MCT) surrounds myofiber bundles to provide structural support, produce force transduction from tendons, and regulate satellite cell differentiation during muscle regeneration. Engineered muscle tissue composed of myofibers layered within MCT has not yet been developed. Herein, a bioengineering strategy to create MCT‐layered myofibers through the development of stem cell fate‐controlling biomaterials that achieve both myogenesis and fibroblast differentiation in a locally controlled manner at the single construct is introduced. The reciprocal role of transforming growth factor‐beta 1 (TGF‐β1) and its inhibitor as well as 3D matrix stiffness to achieve co‐differentiation of MCT fibroblasts and myofibers from a human‐induced pluripotent stem cell (hiPSC)‐derived paraxial mesoderm is studied. To avoid myogenic inhibition, TGF‐β1 is conjugated on the gelatin‐based hydrogel to control the fibroblasts’ populations locally; the TGF‐β1 degrades after 2 weeks, resulting in increased MCT‐specific extracellular matrix (ECM) production. The locations of myofibers and fibroblasts are precisely controlled by using photolithography and co‐axial wet spinning techniques, which results in the formation of MCT‐layered functional myofibers in 3D constructs. This advanced engineering strategy is envisioned as a possible method for obtaining biomimetic human muscle grafts for various biomedical applications.


  • Open Access

    Biomimetic cellular vectors for enhancing drug delivery to the lungs

    by Michael Evangelopoulos, Iman K. Yazdi, Stefania Acciardo, Roberto Palomba, Federica Giordano, Anna Pasto, Manuela Sushnitha, Jonathan O. Martinez, Nupur Basu, Armando Torres, et al.

    Despite recent advances in drug delivery, the targeted treatment of unhealthy cells or tissues continues to remain a priority. In cancer (much like other pathologies), delivery vectors are designed to exploit physical and biological features of unhealthy tissues that are not always homogenous across the disease. In some cases, shifting the target from unhealthy tissues to the whole organ can represent an advantage. Specifically, the natural organ-specific retention of nanotherapeutics following intravenous administration as seen in the lung, liver, and spleen can be strategically exploited to enhance drug delivery. Herein, we outline the development of a cell-based delivery system using macrophages as a delivery vehicle. When loaded with a chemotherapeutic payload (i.e., doxorubicin), these cellular vectors (CELVEC) were shown to provide continued release within the lung. This study provides proof-of-concept evidence of an alternative class of biomimetic delivery vectors that capitalize on cell size to provide therapeutic advantages for pulmonary treatments.


  • Top Cited Papers

    Smart Bandage for Monitoring and Treatment of Chronic Wounds

    by Pooria Mostafalu, Ali Tamayol, Rahim Rahimi, Manuel Ochoa, Akbar Khalilpour, Gita Kiaee, Iman K. Yazdi, Sara Bagherifard, Mehmet R. Dokmeci, Babak Ziaie, et al.

    Chronic wounds are a major health concern and they affect the lives of more than 25 million people in the United States. They are susceptible to infection and are the leading cause of nontraumatic limb amputations worldwide. The wound environment is dynamic, but their healing rate can be enhanced by administration of therapies at the right time. This approach requires real‐time monitoring of the wound environment with on‐demand drug delivery in a closed‐loop manner. In this paper, a smart and automated flexible wound dressing with temperature and pH sensors integrated onto flexible bandages that monitor wound status in real‐time to address this unmet medical need is presented. Moreover, a stimuli‐responsive drug releasing system comprising of a hydrogel loaded with thermo‐responsive drug carriers and an electronically controlled flexible heater is also integrated into the wound dressing to release the drugs on‐demand. The dressing is equipped with a microcontroller to process the data measured by the sensors and to program the drug release protocol for individualized treatment. This flexible smart wound dressing has the potential to significantly impact the treatment of chronic wounds.


  • A low-cost flexible pH sensor array for wound assessment

    by Rahim Rahimi, Manuel Ochoa, Tejasvi Parupudi, Xin Zhao, Iman K. Yazdi, Mehmet R. Dokmeci, Ali Tamayol, Ali Khademhosseini, Babak Ziaie


  • Top Cited Papers
    Open Access

    Biomimetic proteolipid vesicles for targeting inflamed tissues

    by R. Molinaro, C. Corbo, J. O. Martinez, F. Taraballi, M. Evangelopoulos, S. Minardi, I. K. Yazdi, P. Zhao, E. De Rosa, M. B. Sherman, et al.

    A multitude of micro- and nanoparticles have been developed to improve the delivery of systemically administered pharmaceuticals, which are subject to a number of biological barriers that limit their optimal biodistribution. Bioinspired drug-delivery carriers formulated by bottom-up or top-down strategies have emerged as an alternative approach to evade the mononuclear phagocytic system and facilitate transport across the endothelial vessel wall. Here, we describe a method that leverages the advantages of bottom-up and top-down strategies to incorporate proteins derived from the leukocyte plasma membrane into lipid nanoparticles. The resulting proteolipid vesicles—which we refer to as leukosomes—retained the versatility and physicochemical properties typical of liposomal formulations, preferentially targeted inflamed vasculature, enabled the selective and effective delivery of dexamethasone to inflamed tissues, and reduced phlogosis in a localized model of inflammation.


  • Open Access

    One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA

    by Sm Z. Khaled, Armando Cevenini, Iman K. Yazdi, Alessandro Parodi, Michael Evangelopoulos, Claudia Corbo, Shilpa Scaria, Ye Hu, Seth G. Haddix, Bruna Corradetti, et al.


  • Open Access

    Cell source determines the immunological impact of biomimetic nanoparticles

    by Michael Evangelopoulos, Alessandro Parodi, Jonathan O. Martinez, Iman K. Yazdi, Armando Cevenini, Anne L. van de Ven, Nicoletta Quattrocchi, Christian Boada, Nima Taghipour, Claudia Corbo, et al.


  • A New Class of Phantom Materials for Poroelastography Imaging Techniques

    by Anuj Chaudhry, Iman K. Yazdi, Rohit Kongari, Ennio Tasciotti, Raffaella Righetti


  • Physicochemical Properties Affect the Synthesis, Controlled Delivery, Degradation and Pharmacokinetics of Inorganic Nanoporous Materials

    by Iman K Yazdi, Arturas Ziemys, Michael Evangelopoulos, Jonathan O Martinez, Milos Kojic, Ennio Tasciotti

    Controlling size, shape and uniformity of porous constructs remains a major focus of the development of porous materials. Over the past two decades, we have seen significant developments in the fabrication of new, porous-ordered structures using a wide range of materials, resulting in properties well beyond their traditional use. Porous materials have been considered appealing, due to attractive properties such as pore size length, morphology and surface chemistry. Furthermore, their utilization within the life sciences and medicine has resulted in significant developments in pharmaceutics and medical diagnosis. This article focuses on various classes of porous materials, providing an overview of principle concepts with regard to design and fabrication, surface chemistry and loading and release kinetics. Furthermore, predictions from a multiscale mathematical model revealed the role pore length and diameter could have on payload release kinetics.


  • PLGA-Mesoporous Silicon Microspheres for the in Vivo Controlled Temporospatial Delivery of Proteins

    by Silvia Minardi, Laura Pandolfi, Francesca Taraballi, Enrica De Rosa, Iman K. Yazdi, Xeuwu Liu, Mauro Ferrari, Ennio Tasciotti

    In regenerative medicine, the temporospatially controlled delivery of growth factors (GFs) is crucial to trigger the desired healing mechanisms in the target tissues. The uncontrolled release of GFs has been demonstrated to cause severe side effects in the surrounding tissues. The aim of this study was to optimize a translational approach for the fine temporal and spatial control over the release of proteins, in vivo. Hence, we proposed a newly developed multiscale composite microsphere based on a core consisting of the nanostructured silicon multistage vector (MSV) and a poly(dl-lactide-co-glycolide) acid (PLGA) outer shell. Both of the two components of the resulting composite microspheres (PLGA-MSV) can be independently tailored to achieve multiple release kinetics contributing to the control of the release profile of a reporter protein in vitro. The influence of MSV shape (hemispherical or discoidal) and size (1, 3, or 7 μm) on PLGA-MSV’s morphology and size distribution was investigated. Second, the copolymer ratio of the PLGA used to fabricate the outer shell of PLGA-MSV was varied. The composites were fully characterized by optical microscopy, scanning electron microscopy, ζ potential, Fourier transform infrared spectroscopy, and thermogravimetric analysis–differential scanning calorimetry, and their release kinetics over 30 days. PLGA-MSV’s biocompatibility was assessed in vitro with J774 macrophages. Finally, the formulation of PLGA-MSV was selected, which concurrently provided the most consistent microsphere size and allowed for a zero-order release kinetic. The selected PLGA-MSVs were injected in a subcutaneous model in mice, and the in vivo release of the reporter protein was followed over 2 weeks by intravital microscopy, to assess if the zero-order release was preserved. PLGA-MSV was able to retain the payload over 2 weeks, avoiding the initial burst release typical of most drug delivery systems. Finally, histological evaluation assessed the biocompatibility of the platform in vivo.